ANANDA Scientific’s Liquid Structure™ Cannabidiol (CBD) to Be Clinically Evaluated for Opioid Use Disorder

GREENWOOD VILLAGE, Colo. & NEW YORK–(BUSINESS WIRE)–ANANDA Scientific Inc., a biotech pharma company, announced a clinical trial to evaluate Nantheia™ ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology for Opioid Use Disorder. An Investigational New Drug (IND) application has been approved by the U.S. Food and Drug Administration (FDA) for this trial.

Pre-clinical and initial clinical studies show ANANDA’s Liquid Structure technology (licensed from Lyotropic Delivery Systems (LDS) Ltd., Jerusalem, Israel), enhances the effectiveness and stability of CBD. Nantheia™ ATL5 is an oral product with 100mg of CBD per softgel capsule and is ANANDA’s investigational drug utilizing Liquid Structure™ technology.

“This clinical trial with Nantheia™ ATL5 has the possibility to advance applications for CBD in ANANDA’s patented delivery technology in an area that could positively impact the lives of a large number of people suffering from opioid addiction. Opioids are a huge driver of overdose deaths in the U.S. and a non-addictive therapy is a significant unmet need,” said Sohail R. Zaidi, ANANDA’s President.

This trial is being conducted at the Icahn School of Medicine at Mount Sinai led by principal investigator Yasmin L Hurd, Ph.D, the Ward-Coleman Chair of Translational Neuroscience and the Director of the Addiction Institute at Mount Sinai. Funding for this trial was awarded to Dr. Hurd by the National Institute on Drug Abuse (NIDA). (Clinicaltrials.gov Identifier NCT 05203070).

ABOUT ANANDA SCIENTIFIC

ANANDA is a leading research-focused biotech company pioneering high-caliber clinical studies evaluating therapeutic indications for cannabinoids such as PTSD, Radiculopathic Pain, Anxiety and Opioid Use Disorder. The company employs patented delivery technologies to make cannabinoids and other plant derived compounds highly bioavailable, water soluble, and shelf-life stable and focuses on producing effective, premium quality pharmaceutical products. Consistent with its strong research-based data, the company also has a growing pipeline of nutraceutical over-the-counter products. The company has successfully launched these products in the US, Australia, and the UK, with expansion into additional markets such as the EU, China, Africa and other countries in Asia planned for the future. The company is expanding its research base through multiple sponsored research agreements with universities to diversify its technology portfolio.


  • Struggle between large, small growers over Ohio cannabis reform
    A Senate measure that would expand significantly the state’s medical marijuana system for businesses and patients got its second committee hearing Tuesday. The proposal is beginning to move as a different and more expansive recreational measure gathers signatures for next year’s ballot.
  • Reps. Dave Joyce and Alexandria Ocasio-Cortez Introduce Legislation To Expunge Marijuana Records
    Today, Representatives Dave Joyce (R-OH) and Alexandria Ocasio-Cortez (D-NY) introduced legislation to incentivize state and local governments to expunge the criminal records of tens of millions of Americans who have previously been convicted of marijuana offenses.
  • New Jersey Entrepreneurs bring social equity company REEForm to East Coast
    Social justice in cannabis is a popular topic, but actual change is elusive. Two New Jersey cannabis entrepreneurs built a business around making a difference in their community. They’re trying to deliver on the promise of social equity in cannabis. On September 14, New Jerseyians gathered at the Doubletree Hilton in Newark to learn about…
  • Head of NORML optimistic on cannabis banking through NDAA
    While defense bills don’t usually interest cannabis advocates, an amendment added by Representative Ed Perlmutter (D-CO) included the language of the SAFE Banking Act in the NDAA. With the standalone bill stalled in the Senate Banking Committee, an amendment to the “must-pass” legislation could be the key.
  • Advocate responds to SD high court overturning adult-use cannabis
    South Dakota’s highest court sided with the state’s governor today in declaring an amendment legalizing cannabis invalid. Amendment A, which passed with 54% support, would have legalized cannabis for anyone over 21.
  • Organizer says next steps on Ohio adult-use cannabis by month’s end
    Ohio attorney Thomas Haren, a representative of the “Coalition to Regulate Marijuana Like Alcohol,” said he expects that enough signatures will be gathered to move a proposal forward that would allow for adult use, sale, and possession of marijuana in Ohio.
  • Montana regulators will reverse proposed CBD, dispensary worker rules
    The Montana Department of Revenue told lawmakers this week that it will strike a pair of proposed rules implementing the state’s fledgling recreational marijuana program after hearing considerable input from members of the public, the cannabis industry and legislators who warned that the rules veered from the intent of House Bill 701, an act passed this session regulating the adult-use pot.
  • Cannabis prices soar in Louisiana due to regulatory bottleneck
    A regulatory bottleneck in Louisiana’s medical marijuana supply chain has inflated costs far beyond the prices found in other states, according to industry experts who testified at the Louisiana Legislature’s Medical Marijuana Commission meeting Thursday.
  • Critics say AZ ‘social equity’ program makes Big Cannabis even richer
    “This is a program that, as currently written, is designed to fail,” attorney Julie Gunnigle said to Arizona Mirror. Gunnigle up until recently worked for Arizona’s Chapter of NORML, an organization that pushes for the reform of marijuana laws across the United States.
  • Bipartisan bill to reduce Wisconsin cannabis fines introduced
    Wisconsin legislators are taking another crack at a bipartisan push to achieve cannabis reform in the state. A new piece of legislation, co-authored by Rep. Shae Sortwell (R-Gibson), Rep. Sylvia Ortiz-Valez (D-Milwaukee), Sen. Lena Taylor (D-Milwaukee) and Sen. Kathleen Bernier (R- Chippewa Falls), reduces existing penalties for cannabis possession.